Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

United Kingdom — Cornwall Partnership NHS Foundation Trust

Tracked across 2 events · 12 articles · First seen Sep 02, 2026 · Last active Sep 05, 2026

Sentiment
32
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 60
Tech
The PrevenTron phase III clinical trial, led by United Kingdom — Cornwall Partnership NHS Foundation Trust in the UK, will test whether the experimental Alzheimer's drug trontinemab, developed by Roche, can prevent dementia in healthy…
Impact: The trust is the lead site in Europe for the trial, enhancing its research reputation and potentially attracting funding and partnerships.
Sep 04, 2026 · 6 articles
2 5
Tech
Impact: Collaborating NHS trust, providing clinical perspective. Minor reputational benefit.
Sep 02, 2026 · 6 articles
ERGEN INTELLIGENCE
Track United Kingdom — Cornwall Partnership NHS Foundation Trust live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.